Published in Community Ment Health J on July 25, 2010
A System for Preference Assessment in Mental Health (SPA) | NCT02183844
Quality of medical care for persons with serious mental illness: A comprehensive review. Schizophr Res (2015) 0.89
SMI life goals: description of a randomized trial of a collaborative care model to improve outcomes for persons with serious mental illness. Contemp Clin Trials (2014) 0.85
Guideline-concordant antipsychotic use and mortality in schizophrenia. Schizophr Bull (2012) 0.83
A computer-assisted motivational social network intervention to reduce alcohol, drug and HIV risk behaviors among Housing First residents. Addict Sci Clin Pract (2016) 0.77
Using patient-facing kiosks to support quality improvement at mental health clinics. Med Care (2013) 0.77
Improving Physical Health in Patients With Chronic Mental Disorders: Twelve-Month Results From a Randomized Controlled Collaborative Care Trial. J Clin Psychiatry (2016) 0.75
The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med (2001) 76.04
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction (1993) 41.55
Adherence to medication. N Engl J Med (2005) 39.77
The Brief Symptom Inventory: an introductory report. Psychol Med (1983) 22.83
Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care (1986) 22.65
The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med (1998) 16.62
The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry (1974) 16.18
The drug abuse screening test. Addict Behav (1982) 9.55
The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry (1971) 9.16
Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care (2004) 9.16
Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. N Engl J Med (2003) 8.74
Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med (2002) 8.18
Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med (2004) 6.86
Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry (2004) 6.40
Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry (2002) 5.25
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction (2002) 5.07
Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care (2004) 4.92
Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv (2004) 4.16
The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol (1995) 4.15
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry (2006) 4.12
Effectiveness of the derived Alcohol Use Disorders Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US general population. Alcohol Clin Exp Res (2005) 3.96
Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry (1995) 3.92
Physical health monitoring of patients with schizophrenia. Am J Psychiatry (2004) 3.54
A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med (1983) 3.46
Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry (2004) 3.26
The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther (2000) 3.07
Overview of the Veterans Health Administration (VHA) Quality Enhancement Research Initiative (QUERI). J Am Med Inform Assoc (2004) 2.78
Interventions to improve medication adherence in schizophrenia. Am J Psychiatry (2002) 2.78
Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care (2002) 2.68
Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med (2002) 2.64
The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009. Schizophr Bull (2009) 2.61
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry (2001) 2.35
From understanding health care provider behavior to improving health care: the QUERI framework for quality improvement. Quality Enhancement Research Initiative. Med Care (2000) 2.12
A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine. J Clin Psychiatry (2008) 1.94
Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry (2007) 1.94
The Revised Behavior and Symptom Identification Scale (BASIS-R): reliability and validity. Med Care (2004) 1.81
The effect of family interventions on relapse and rehospitalization in schizophrenia--a meta-analysis. Schizophr Bull (2001) 1.72
A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp). Med Care (2007) 1.69
Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles. Schizophr Bull (2002) 1.68
Helping people with severe mental illness to obtain work: systematic review. BMJ (2001) 1.66
Advancing evidence-based care for diabetes: lessons from the Veterans Health Administration. Health Aff (Millwood) (2007) 1.53
Effects of sustained audit/feedback on self-reported health status of primary care patients. Am J Med (2004) 1.52
Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry (2005) 1.50
A two-item screening test for alcohol and other drug problems. J Fam Pract (1997) 1.43
Comparison of the Brief Psychiatric Rating Scale and the Brief Symptom Inventory. J Clin Psychol (1998) 1.41
A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. J Clin Psychiatry (2008) 1.39
Measuring the quality of outpatient treatment for schizophrenia. Arch Gen Psychiatry (1998) 1.36
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. J Clin Psychiatry (2004) 1.35
Screening for alcohol-related problems in an outpatient obstetric-gynecologic clinic. Am J Obstet Gynecol (1979) 1.34
Improving performance through knowledge translation in the Veterans Health Administration. J Contin Educ Health Prof (2006) 1.28
Computer-assisted self-assessment in persons with severe mental illness. J Clin Psychiatry (2004) 1.28
Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr Serv (2007) 1.23
The Level of Expressed Emotion Scale: a new measure of expressed emotion. J Clin Psychol (1988) 1.19
The MIRECC version of the Global Assessment of Functioning scale: reliability and validity. Psychiatr Serv (2007) 1.15
Employment outcomes in family-aided assertive community treatment. Am J Orthopsychiatry (2000) 1.13
The effect of a managed behavioral health carve-out on quality of care for medicaid patients diagnosed as having schizophrenia. Arch Gen Psychiatry (2004) 1.12
Toward the implementation of mental health consumer provider services. J Behav Health Serv Res (2006) 1.12
Quality of care in mental health: the case of schizophrenia. Health Aff (Millwood) (1999) 1.04
An instrument for measurement of outcomes of care for schizophrenia. Issues in development and implementation. Eval Health Prof (1997) 1.03
Cognitive therapy: past, present, and future. J Consult Clin Psychol (1993) 1.02
Rejecting the patient: preliminary validation of a self-report scale. Schizophr Bull (1979) 1.01
Identifying highly effective psychotherapists in a managed care environment. Am J Manag Care (2005) 0.99
The Indiana Job Satisfaction Scale: job satisfaction in vocational rehabilitation for people with severe mental illness. Psychiatr Rehabil J (2001) 0.97
The feasibility of computerized patient self-assessment at mental health clinics. Adm Policy Ment Health (2007) 0.94
The Family Attitude Scale: reliability and validity of a new scale for measuring the emotional climate of families. Psychiatry Res (1997) 0.94
Factor structure and discriminant validity of the SCL-90 in a veteran psychiatric population. J Pers Assess (1983) 0.94
SCL-90-R factor structure in an acute, involuntary, adult psychiatric inpatient sample. J Clin Psychol (1996) 0.93
An examination of the utility of the AUDIT in people with schizophrenia. J Stud Alcohol (2000) 0.93
A randomized controlled trial of integrated versus parallel housing services for homeless adults with severe mental illness. Schizophr Bull (2004) 0.93
Psychometric properties of the Drug Abuse Screening Test in a psychiatric patient population. Addict Behav (1990) 0.92
The validity of using patient self-report to assess psychotic symptoms in schizophrenia. Schizophr Res (2007) 0.87
The brief symptom inventory and the positive and negative syndrome scale: discriminate validity between a self-reported and observational measure of psychopathology. Compr Psychiatry (2003) 0.87
Housing status among formerly homeless dually diagnosed adults. Psychiatr Serv (1997) 0.86
Suicidal behavior in adolescent psychiatric inpatients. J Am Acad Child Adolesc Psychiatry (1988) 0.85
Use of the Beck Scale for suicide ideation with psychiatric inpatients diagnosed with schizophrenia, schizoaffective, or bipolar disorders. Behav Res Ther (2002) 0.84
Using information systems to improve care for persons with schizophrenia. Psychiatr Serv (2004) 0.82
Correlates of family contact with the mental health system: allocation of a scarce resource. Ment Health Serv Res (2005) 0.82
Evaluating and improving the appropriateness of treatment for schizophrenia. Harv Rev Psychiatry (1999) 0.80
An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder. Schizophr Res (2005) 0.79
Detection of alcoholism in schizophrenia using the MAST. Alcohol Clin Exp Res (1993) 0.78
Routinely measuring schizophrenia treatment quality--shortcomings with medical records. Med Care (2007) 0.77
Identification of the alcoholic schizophrenic: use of clinical laboratory tests and the MAST. J Stud Alcohol (1989) 0.75
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry (2008) 9.00
Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA (2011) 7.17
Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry (2005) 6.27
The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull (2006) 5.59
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry (2004) 4.46
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry (2008) 4.02
Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. Am J Psychiatry (2008) 3.29
The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Am J Psychiatry (2007) 2.89
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry (2003) 2.83
The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone. Biol Psychiatry (2002) 2.70
Suicide mortality among patients receiving care in the veterans health administration health system. Am J Epidemiol (2009) 2.66
Risk of mortality among individual antipsychotics in patients with dementia. Am J Psychiatry (2011) 2.59
Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry (2007) 2.41
The brief negative symptom scale: psychometric properties. Schizophr Bull (2010) 2.27
Peer support among adults with serious mental illness: a report from the field. Schizophr Bull (2006) 2.19
Bipolar I disorder: psychopathology, medical management and dental implications. J Am Dent Assoc (2002) 2.15
Alcohol abuse and dependence: psychopathology, medical management and dental implications. J Am Dent Assoc (2003) 2.09
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry (2010) 1.99
Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull (2009) 1.95
Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia. Psychiatr Serv (2007) 1.93
Family psychoeducation and schizophrenia: a review of the literature. J Marital Fam Ther (2003) 1.93
Use, quality, and outcomes of care for mental health: the rural perspective. Med Care Res Rev (2002) 1.91
Suicide mortality among individuals receiving treatment for depression in the Veterans Affairs health system: associations with patient and treatment setting characteristics. Am J Public Health (2007) 1.90
Content validity in the PROMIS social-health domain: a qualitative analysis of focus-group data. Qual Life Res (2008) 1.87
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. Am J Psychiatry (2011) 1.86
Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophr Res (2006) 1.80
Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns. Psychiatr Serv (2007) 1.79
The cortex as a central pattern generator. Nat Rev Neurosci (2005) 1.79
Models, strategies, and tools. Theory in implementing evidence-based findings into health care practice. J Gen Intern Med (2006) 1.77
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. J Clin Psychiatry (2007) 1.73
Measuring the quality of depression care in a large integrated health system. Med Care (2003) 1.69
The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry (2002) 1.68
Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord (2006) 1.66
Efficacy of peer support interventions for depression: a meta-analysis. Gen Hosp Psychiatry (2010) 1.63
Psychopathology, Iraq and Afghanistan service, and suicide among Veterans Health Administration patients. J Consult Clin Psychol (2012) 1.59
Trends in antipsychotic use in dementia 1999-2007. Arch Gen Psychiatry (2011) 1.58
Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry (2005) 1.58
Variation in practices and attitudes of clinicians assessing PTSD-related disability among veterans. J Trauma Stress (2011) 1.58
Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. Am J Psychiatry (2004) 1.54
Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients. Liver Transpl (2009) 1.52
Psychosocial treatments to promote functional recovery in schizophrenia. Schizophr Bull (2009) 1.52
A comparison of guidelines for the treatment of schizophrenia. Psychiatr Serv (2002) 1.51
Addressing the needs of patients with multiple chronic illnesses: the case of diabetes and depression. Am J Manag Care (2004) 1.51
A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prev (2006) 1.51
Sleep problems and suicidality in the National Comorbidity Survey Replication. J Psychiatr Res (2008) 1.50
Impact of evidence-based standardized assessment on the disability clinical interview for diagnosis of service-connected PTSD: a cluster-randomized trial. J Trauma Stress (2012) 1.49
Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety. Pediatr Pulmonol (2007) 1.46
Initiation of Primary Care-Mental Health Integration programs in the VA Health System: associations with psychiatric diagnoses in primary care. Med Care (2010) 1.46
Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv (2007) 1.46
Veterans Affairs Health System and mental health treatment retention among patients with serious mental illness: evaluating accessibility and availability barriers. Health Serv Res (2007) 1.45
Depressive symptoms, smoking, drinking, and quality of life among head and neck cancer patients. Psychosomatics (2007) 1.44
Panic disorder: psychopathology, medical management and dental implications. J Am Dent Assoc (2004) 1.44
Initiation of assertive community treatment among veterans with serious mental illness: client and program factors. Psychiatr Serv (2009) 1.44
A pilot study of barriers to medication adherence in schizophrenia. J Clin Psychiatry (2004) 1.43
The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophr Res (2010) 1.43
Telephone monitoring and support after discharge from residential PTSD treatment: a randomized controlled trial. Psychiatr Serv (2013) 1.41
A randomized trial of telephonic counseling plus walking for depressed diabetes patients. Med Care (2011) 1.40
Criminal background checks for psychiatry? Michigan's mental health exceptionalism. J Am Acad Psychiatry Law (2008) 1.39
Peer support services for individuals with serious mental illnesses: assessing the evidence. Psychiatr Serv (2014) 1.39
International emergency medicine and the role for academic emergency medicine. Acad Emerg Med (2007) 1.39
Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy. J Clin Psychopharmacol (2005) 1.39
Physician signatures. South Med J (2008) 1.39
Pain and suicidal thoughts, plans and attempts in the United States. Gen Hosp Psychiatry (2008) 1.38
Diabetes treatment among VA patients with comorbid serious mental illness. Psychiatr Serv (2006) 1.37
The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later? Schizophr Bull (2010) 1.36
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. J Clin Psychiatry (2004) 1.35
Treatment of schizophrenia negative symptoms: future prospects. Schizophr Bull (2006) 1.35
Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol. Am J Psychiatry (2007) 1.32
Effect of smoking, alcohol, and depression on the quality of life of head and neck cancer patients. Gen Hosp Psychiatry (2002) 1.30
A process for developing an implementation intervention: QUERI Series. Implement Sci (2008) 1.30
Comorbid anxiety as a suicide risk factor among depressed veterans. Depress Anxiety (2009) 1.27
Validation of key behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco use. BMC Health Serv Res (2012) 1.27
Implementing research findings into practice using clinical opinion leaders: barriers and lessons learned. Jt Comm J Qual Patient Saf (2005) 1.26
Mechanistic investigation of beta-galactosidase-activated MR contrast agents. Inorg Chem (2007) 1.24
Risk of death from accidental overdose associated with psychiatric and substance use disorders. Am J Psychiatry (2011) 1.23
Prevalence and correlates of alcohol misuse among returning Afghanistan and Iraq veterans. Addict Behav (2011) 1.23
Recent developments in family psychoeducation as an evidence-based practice. J Marital Fam Ther (2011) 1.22
Prefrontal-posterior parietal networks in schizophrenia: primary dysfunctions and secondary compensations. Biol Psychiatry (2003) 1.22
Sex, race, and smoking impact olanzapine exposure. J Clin Pharmacol (2008) 1.21
Suicide risk and precipitating circumstances among young, middle-aged, and older male veterans. Am J Public Health (2012) 1.21
Are mobile phones and handheld computers being used to enhance delivery of psychiatric treatment? A systematic review. J Nerv Ment Dis (2011) 1.21
A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy. J Clin Psychiatry (2009) 1.20
Conceptual foundation for measures of physical function and behavioral health function for Social Security work disability evaluation. Arch Phys Med Rehabil (2013) 1.20
Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders. J Psychiatr Res (2011) 1.20
Social relationships and depression: ten-year follow-up from a nationally representative study. PLoS One (2013) 1.19
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophr Res (2011) 1.17
Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for postexposure prophylaxis. Clin Vaccine Immunol (2013) 1.17
Measuring social health in the patient-reported outcomes measurement information system (PROMIS): item bank development and testing. Qual Life Res (2010) 1.17
Guideline recommendations for treatment of schizophrenia: the impact of managed care. Arch Gen Psychiatry (2003) 1.16
Gender and comorbidity among individuals with opioid use disorders in the NESARC study. Addict Behav (2009) 1.15
Perceptions of need and help received for substance dependence in a national probability survey. Psychiatr Serv (2009) 1.14
Report from the working group conference on multisite trial design for cognitive remediation in schizophrenia. Schizophr Bull (2010) 1.13
Interleukin-1 stimulates catabolism in C2C12 myotubes. Am J Physiol Cell Physiol (2009) 1.13
Schizophrenia, IX: Cognition in schizophrenia--the MATRICS initiative. Am J Psychiatry (2004) 1.13
Developing a national dissemination plan for collaborative care for depression: QUERI Series. Implement Sci (2008) 1.13